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Diabetes mellitus has become a major cause of death 
worldwide and diabetic ketoacidosis is the most common 
cause of death in children and adolescents with type 1 di-
abetes. Acute complications of diabetes mellitus as caus-
es of death may be difficult to diagnose due to missing 
characteristic macroscopic and microscopic findings. Bio-
chemical analyses, including vitreous glucose, blood (or 
alternative specimen) beta-hydroxybutyrate, and blood 
glycated hemoglobin determination, may complement 
postmortem investigations and provide useful informa-
tion for determining the cause of death even in corpses 
with advanced decompositional changes. In this article, 
we performed a review of the literature pertaining to the 
diagnostic performance of classical and novel biochemical 
parameters that may be used in the forensic casework to 
identify disorders in glucose metabolism. We also present 
a review focusing on the usefulness of traditional and alter-
native specimens that can be sampled and subsequently 
analyzed to diagnose acute complications of diabetes mel-
litus as causes of death.
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Diabetes mellitus has become a major cause of death 
worldwide in people younger than 60 years. Over the past 
three decades, the number of people with diabetes mellitus 
has more than doubled globally, making it one of the most 
important public health challenges to all nations (1). World-
wide, 382 million adults (8.3%) are living with diabetes, and 
the estimate is projected to rise to more than 592 million by 
2035. At least US $147 billion was spent on diabetes health 
care in Europe in 2013, whereas North America and the Ca-
ribbean spent $263 billion (2). Currently, in Australia, approx-
imately 4.0% of people aged 15 years and over has been 
diagnosed with diabetes. Some estimates suggest that this 
figure will rise to as much as 2 million by 2025 as a result of 
increasing obesity and aging as well as changes in the eth-
nic composition of the Australian population (2,3).
Type 1 diabetes is characterized by cellular-mediated au-
toimmune destruction of pancreatic beta-cells resulting 
in insulin deficiency and, thus, hyperglycemia (4,5). In the 
United States, Canada, and Europe, type 1 diabetes ac-
counts for 5 to 10% of all cases of diabetes. A second and 
more prevalent category, type 2 diabetes, is characterized 
by a combination of insulin resistance and inadequate 
compensatory insulin secretory response (5,6).
Prevalence and morbidity data in cases of already diag-
nosed diabetes underestimate the actual burden of the 
disease since it is usually not diagnosed until it has become 
clinically apparent and complications occur. A number of 
local and national surveys have reported both diagnosed 
and undiagnosed diabetes rates based on population 
health surveys, though the relative prevalence of diag-
nosed and undiagnosed cases varies widely. The North-
West Adelaide Health Survey, for example, found a ratio 
of 5–6:1 for diagnosed vs undiagnosed diabetes, consis-
tent with the latest Australian Bureau of Statistics National 
Health Survey data showing a ratio of 5:1, whereas a pre-
vious Australian Diabetes, Obesity and Lifestyle Study es-
timated one undiagnosed case for every diagnosed case 
in Australia (3,7). Analogously, a high proportion of the es-
timated 26 million Americans with diabetes remains un-
diagnosed and unaware of their disease, and more than 
90% of the estimated 79 million adults with pre-diabetes 
remains undetected (8,9).
Diabetic ketoacidosis (DKA) is a life-threatening condition 
that can occur when there is a complete lack of insulin, as 
in type 1 diabetes, or inadequate insulin levels associated 
with stress or severe illness in either type 1 or type 2 dia-
betes (10). It has been estimated that nearly a third 
of all deaths from DKA occurs in individuals with no known 
history of diabetes (6,11).
DKA is the most common cause of death in children and 
adolescents with type 1 diabetes and accounts for half of 
all deaths in diabetic patients younger than 24 years of age 
(12). Depending on the reports, DKA at the clinical diag-
nosis of type 1 diabetes in the pediatric population may 
range from 15% to more than 77% of cases (13).
In the realm of forensic pathology, acute complications 
of diabetes mellitus as causes of death may be difficult to 
diagnose due to missing characteristic macroscopic and 
microscopic findings. Nevertheless, when biochemical in-
vestigations complement autopsy and histology, fatal DKA 
can be easily diagnosed despite unknown disease histo-
ry and even in corpses with advanced decompositional 
changes (6,14,15).
The aim of this article is to perform a review of the literature 
pertaining to the diagnostic performance of classical and 
novel biomarkers that may be used in forensic pathology 
routine to identify disorders in glucose metabolism. More-
over, we wish to present a review of the literature focusing 
on the usefulness of traditional and alternative specimens 
that can be sampled at autopsy and subsequently ana-
lyzed to diagnose acute complications of diabetes mellitus 
as causes of death.
Vitreous gluCose
In clinical practice, the most important biochemical mark-
ers to identify disorders in glucose metabolism are blood 
glucose concentration and glycated hemoglobin levels. 
In the realm of forensic pathology, postmortem blood 
glucose concentration is unreliable and of no diagnos-
tic value in estimating antemortem blood glucose levels 
due to substantial fluctuations in glucose concentrations 
after death. After the cessation of cardiac and respiratory 
functions, surviving cells continue to metabolize blood 
glucose for some time and glycolysis continues sponta-
neously, causing a rapid decrease in blood glucose levels. 
Furthermore, death may be preceded by agonal process-
es and/or cardiopulmonary resuscitation, often associated 
with catecholamine release or administration. This results 
in subsequent mobilization of liver glycogen and increas-
es in blood glucose concentrations as a counterbalanc-
ing phenomenon. Another possible pitfall in estimating 
antemortem blood glucose values using postmortem 
blood glucose concentrations is the variation of glucose 
183Palmiere: Postmortem diagnosis of diabetes mellitus and its complications
www.cmj.hr
levels depending on the sampling site. The highest blood 
glucose concentrations have been found in hepatic vein 
blood, followed by inferior vena cava, superior vena cava, 
and cardiac right ventricle blood, likely following glycogen 
breakdown in the liver. Considering the difficulties in in-
terpreting glucose levels in postmortem blood, determi-
nation of glucose concentrations and those of its metabo-
lites in biological fluids other than blood, such as vitreous 
humor and cerebrospinal fluid, was proposed in order to 
detect antemortem hyperglycemia (6,11,16-19).
Assuming that anaerobic glycolysis continues spontane-
ously after death and that two molecules of lactic acid are 
the final product of the postmortem glycolysis of one mol-
ecule of glucose, Traub (20) speculated that blood glucose 
concentrations at the time of death could be estimated by 
combining the values of glucose and lactate in cerebro-
spinal fluid
Blood glucose concentration at the time of death:
Glucose cerebrospinal fluid concentration + (Lactate cere-
brospinal fluid concentration/2)
Succeeding Traub, other research teams have reasserted 
the applicability and reliability of this formula in vitreous 
humor or cerebrospinal fluid in order to predict glucose 
values shortly preceding death (21-26).
Karlovsek (27,28) compared glycated hemoglobin, glucose, 
lactate, and combined glucose and lactate concentrations 
in vitreous and cerebrospinal fluid in a series of medico-le-
gal cases including diabetics and control individuals. Based 
on her results, Karlovsek proposed that vitreous glucose 
concentrations over 13 mmol/L (234 mg/dL) or combined 
glucose and lactate levels in vitreous humor or cerebrospi-
nal fluid over 23.7 mmol/L (427 mg/dL) and 23.4 (422 mg/
dL), respectively, could indicate antemortem hyperglyce-
mia with a fatal outcome, thus suggesting that increased 
vitreous glucose levels alone were diagnostic of antemor-
tem blood hyperglycemia. The additional measurements 
of glycated hemoglobin, acetone, acetoacetate, and beta-
hydroxybutyrate were also recommended in order to con-
firm or exclude DKA as the cause of death.
Zilg et al (29) measured glucose and lactate in vitreous 
humor sampled as soon as possible after corpse arrival at 
the morgue in a large series of medico-legal cases. They 
observed that after an initial decrease in vitreous glucose 
levels during the very early postmortem period, glucose 
concentrations did not undergo substantial changes for an 
appreciable amount of time after death. Conversely, vitre-
ous lactate levels constantly increased as postmortem in-
terval lengthened, as did, consequently, the combined val-
ue of vitreous glucose and lactate. On the other hand, they 
(29) postulated that the presence of lactate in the vitreous 
could be due not only to postmortem glucose metabo-
lism, but to other sources responsible for its formation and 
subsequent increased concentrations in the vitreous after 
death. Based on these findings, the authors postulated that 
vitreous glucose alone could be used to estimate blood 
glucose levels at the time of death. In addition, they pro-
posed that vitreous glucose values over 10 mmol/L (180 
mg/dL), theoretically corresponding to antemortem blood 
glucose concentrations of approximately 26 mmol/L (468 
mg/dL), might indicate death due to acute complications 
of diabetes (DKA or hyperosmolar hyperglycemic states, 
based on ketone levels) or, in the least, that hyperglycemia 
might contribute to death.
Similar results were obtained by Palmiere et al (30) in a se-
ries of medico-legal cases including diabetics and control 
individuals. These authors concluded that vitreous glucose 
alone was more reliable than the sum value of vitreous (or 
cerebrospinal fluid) glucose and lactate in order to estimate 
antemortem blood glucose levels. They also reasserted the 
importance of simultaneous determination of blood gly-
cated hemoglobin, acetone, and beta-hydroxybutyrate, as 
well as urine glucose, to better characterize the metabolic 
profile of individual cases and confirm (or rule out) DKA as 
cause of death.
In a review article published in 2011, Hess et al (17) con-
cluded that, due to the considerable influence of environ-
mental temperatures in glycolysis, the Traub formula was 
still up-to-date and should be considered when estimat-
ing antemortem glucose levels. However, these authors 
did emphasize that lactate values could be increased for 
reasons other than antemortem glucose metabolism dis-
turbances, such as malignant tumors, alcohol-induced lac-
tic acidosis, respiratory insufficiency, and inflammation. 
Nevertheless, in a paper published in 2013, Hess et al (6) 
concluded that post-mortem vitreous lactate determina-
tion did not seem to provide further information and could 
therefore be omitted.
In their recent study, Keltanen et al (31) took a balanced, 
mid-way position between the two opposing statements 
regarding the Traub formula reliability. They concluded 
that combined glucose and lactate values may be 
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elevated in cases of antemortem hyperglycemia, though 
not exclusively in cases of antemortem hyperglycemia, 
and that the Traub formula should not be used for diag-
nosing hyperglycemia, though it does prove useful in in-
terpreting vitreous glucose and lactate levels in cases with 
relatively long postmortem intervals and low vitreous glu-
cose values, possibly due to prolonged postmortem gly-
colysis. Furthermore, they asserted that higher combined 
glucose and lactate values in the vitreous, though not di-
agnostic per se, should prompt pathologists to look for 
complementing postmortem biochemical investigations. 
Examples of these are glycated hemoglobin and beta-hy-
droxybutyrate determination, the latter being the most re-
liable indicator of ketoacidosis and its severity.
glYCAteD HeMogloBiN AND otHer glYCAteD 
ProteiNs
The glycation process results from a spontaneous reaction 
between the aldehyde group of a monosaccharide (usu-
ally glucose) and the free amine groups of peptides, such 
as hemoglobin, albumin, and other serum proteins. Glycat-
ed hemoglobin consists of several fractions that differ not 
only in the location of the glycated amine group but also 
in the type of attached monosaccharide. The biggest frac-
tion of glycohemoglobin is, however, glycated hemoglo-
bin HbA1c, produced by a two-step, irreversible, non-en-
zymatic, post-translational, spontaneous reaction between 
D-glucose and the N-terminal amine group of the hemo-
globin β chain. The rate of this reaction is determined by 
the concentration of glucose in the blood (32).
HbA1c is the most widely used measurement in evaluating 
long-term glycemic control as well as the risk for complica-
tion development in patients with type 1 or 2 diabetes. Nev-
ertheless, HbA1c determination is known to be effected by 
hematologic conditions that change erythrocyte survival 
or diseases characterized by variant hemoglobins, possibly 
responsible for erroneous glycemic control evaluation. Hy-
perglycemia is also known to reduce erythrocyte survival, 
thereby leading to an underestimation of HbA1c levels in 
diabetic patients with poor glycemic control (33-35).
In addition to hemoglobin, most serum proteins undergo 
non-enzymatic glycation in both euglycemic and diabet-
ic patients in relation to the blood glucose levels they are 
exposed to in their life-spans. Measurements of glycat-
ed albumin and glycated total proteins, the latter com-
monly referred to as fructosamine, may be used as the 
determination of glycated hemoglobin. These mea-
surements have therefore been proposed as useful tools 
for glycemic control evaluation in diabetics. The level of 
glycated albumin or glycated total proteins in plasma or 
serum reflects shorter-term glycemic control in diabetics 
because they have a shorter half-life than glycated hemo-
globin. Serum glycated albumin has been reported as a 
useful, reliable indicator of glycemic control in diabetic pa-
tients since the serum albumin turnover is much shorter 
(17-day half-life) than that of HbA1c. Circulating albumin 
is strongly glycated at four sites of lysine residues, with the 
glycation reaction occurring ten times more rapidly than 
that of hemoglobin. Analogously, serum fructosamine, 
produced by the spontaneous, non-enzymatic glycation 
of serum proteins, has a shorter half-life than HbA1c and 
reflects very recent (1–3 weeks) glycemic control. This may 
potentially lessen the confounding effects of shortened 
red cell survival or high red cell turnover seen with HbA1c 
levels. Fructosamine concentration largely reflects glycat-
ed albumin concentration, even though a limited amount 
of fructosamine is made up of other serum proteins. Gly-
cation of serum proteins with very short half-lives should 
reflect recent metabolic fluctuations in glycemic control 
even more than glycated hemoglobin, glycated albumin, 
and glycated total proteins (36-40).
In forensic pathology routine, HbA1c is a useful mark-
er to characterize the metabolic state of the deceased in 
the weeks prior to death. HbA1c is measured in whole 
blood. Unlike glucose, it is fairly stable after death and cor-
responds well to antemortem values. Nonetheless, some 
discrepancies may arise when blood samples are markedly 
hemolyzed or putrefied (6,11,16,17,19,32,41-49).
Wineker et al (47) found no differences in HbA1c values if 
blood samples were stored in tubes with EDTA or sodium 
fluoride. Hindle et al (42) and Goullé et al (48) observed 
that HbA1c determination was possible in whole blood 
specimens stored at 4°C for about 40 days in samples col-
lected with EDTA, for about 3 months in samples collected 
with sodium fluoride, and for 6 months in samples collect-
ed in dry or heparinized tubes.
Uemura et al (49) investigated a series of laboratory param-
eters, including glycated hemoglobin and fructosamine, 
in whole blood (for glycated hemoglobin) and postmor-
tem serum (for fructosamine) obtained from three differ-
ent sampling sites (left cardiac blood, right cardiac blood, 
and femoral vein blood) in a series of consecutive forensic 
autopsy cases. Though HbA1c values measured in femoral 
blood were lower than those measured in cardiac blood, 
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both HbA1c and fructosamine could be reliably deter-
mined in specimens (whole blood or postmortem serum) 
obtained from any sampling site. Of all tested laboratory 
parameters, glycated hemoglobin showed the smallest 
deviation from living subjects, negligible postmortem 
changes, and no differences due to the cause of death. On 
the contrary, fructosamine showed a large deviation from 
living subjects. The authors postulated that different post-
mortem chemical behaviors of HbA1c and fructosamine 
could be related to the nature of the tested parameter. In-
deed, hemoglobin glycation in the living is a cumulative 
process, whose rate depends on the level of prevailing 
glucose concentration under the lifespan of erythrocytes. 
Conversely, serum fructosamine concentrations reflect its 
normal destruction or elimination by functioning organs.
Glycated albumin and fructosamine in postmortem sam-
ples obtained from diabetics and control cases were inves-
tigated by several authors (50-53). John et al (50) and Akane 
et al (51,52) experienced significant difficulties in measur-
ing fructosamine after death due to highly hemolyzed or 
extremely hemoconcentrated samples, which rendered 
the material unsuitable for analysis. Conversely, Valenzuela 
(53) obtained encouraging results from fructosamine as-
says, confirming its usefulness for the postmortem diagno-
sis of diabetes mellitus.
Ritz et al (40) studied in vitro α1-antitrypsin and hapto-
globin glycation as well as glycated α1-antitrypsin and 
haptoglobin resistance to autolysis. They found that both 
proteins underwent in vitro glycation considerably more 
rapidly than either albumin or hemoglobin and that gly-
cation proved to be highly resistant to autolysis. Glycated 
α1-antitrypsin and haptoglobin levels were further deter-
mined in blood obtained from living diabetics and non-
diabetic control individuals as well as in blood obtained 
from diabetic cadavers. The results of these analyses re-
vealed that glycated α1-antitrypsin and haptoglobin levels 
closely reflected blood glucose concentrations at the time 
of blood sampling (in the living) or shortly before death, 
thus indicating that the postmortem determination of 
both parameters might be a useful laboratory tool for the 
postmortem diagnosis of diabetes.
Lastly, only four studies evaluated glucose and fruc-
tosamine concentrations in vitreous humor samples ob-
tained after death from diabetics and control cases. Osuna 
et al (54,55) and Vivero et al (56) noticed higher levels of 
both parameters in diabetics compared to control individ-
uals. These results suggested that combined increased glu-
cose and fructosamine levels in the vitreous might support 
the hypothesis of antemortem hyperglycemia and diabe-
tes mellitus (6,54-57). Hess et al (6) observed significant dif-
ferences in blood fructosamine concentrations between 
diabetics and non-diabetics. Conversely, no significant dif-
ferences were found in cerebrospinal fluid and vitreous 
fructosamine levels.
ACetoNe, ACetoACetAte, AND BetA-
HYDroXYButYrAte
Ketone bodies, sometimes incorrectly called ketones, in-
clude three molecules: acetoacetate, beta-hydroxybu-
tyrate, and acetone. Ketones are organic compounds that 
contain a chemical group consisting of a carbon atom dou-
ble-bonded to an oxygen atom and also bonded to two 
other carbon atoms. Examples of ketones are pyruvate and 
fructose. Acetone and acetoacetate are both ketones and 
ketone bodies. Chemically speaking, beta-hydroxybutyrate 
is not a ketone, though it is classified as a ketone body be-
cause it exists in equilibrium with acetoacetate. Both ace-
toacetate and beta-hydroxybutyrate are acid anions, mean-
ing that increased levels of these compounds result in a 
drop of blood pH and subsequent (keto)acidosis. Ketone 
bodies are a by-product of fat metabolism and are primarily 
synthesized in the liver as an alternative energy source. In 
diabetics, enhanced ketone body production is the conse-
quence of the inability to use glucose due to insulin insuffi-
ciency or insulin resistance. In other physiological and path-
ological conditions, such as prolonged fasting, enhanced 
ketone body synthesis is the result of glucose unavailability. 
Ketone bodies are mainly produced within the mitochon-
dria of hepatocytes, in particular within perivenous hepa-
tocytes. Acetoacetate and beta-hydroxybutyrate are ener-
gy-rich compounds that transport energy from the liver to 
other tissues. They can be interconverted by the enzyme 
beta-hydroxybutyrate dehydrogenase. Acetone is gener-
ated through the decarboxylation of acetoacetate (either 
spontaneously or through the enzyme acetoacetate de-
carboxylase) and is generally considered of little metabolic 
significance. Increased levels of isopropyl alcohol, a ketone 
body-related compound, have been observed in numerous 
clinical conditions characterized by increased ketone body 
levels in blood and elevated NADH/NAD+ ratios. In these 
situations, isopropyl alcohol excess is thought to be the re-
sult of acetone metabolism and its conversion by the en-
zyme alcohol dehydrogenase (58-60).
Diabetes mellitus is the most common pathologic 
cause of increased ketone body production and 
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subsequent ketoacidosis. The hallmark of DKA is relative 
insulin deficiency (type I diabetes) or a major increase in 
insulin resistance (type II diabetes), both resulting in hyper-
glycemia, whereas alcoholic ketoacidosis and starvation 
ketoacidosis are usually associated with reduced nutrition-
al intake thereby accompanied by hypoglycemia (61-66).
Postmortem investigations of ketone bodies in blood and 
other biological fluids have been carried out by several re-
searchers (18,19,61,62). Beta-hydroxybutyrate seems to be 
a better postmortem indicator of ketoacidosis than ace-
tone (57,62).
Kanetake et al (67) measured postmortem serum ketone 
body levels in a series of autopsy cases including diabetics 
and alcoholics. These authors proposed that beta-hydroxy-
butyrate concentrations over 1000 µmol/L (corresponding 
to 10.4 mg/dL) might indicate ketoacidosis as the cause 
of death in situations characterized by enhanced ketone 
body production.
Iten and Meier (68) investigated blood concentrations of 
beta-hydroxybutyrate in cases of diabetics and alcoholic 
ketoacidosis. They proposed that blood beta-hydroxybu-
tyrate concentrations up to 500 µmol/L (corresponding to 
5.2 mg/dL) might be regarded as normal, from 500 to 2500 
µmol/L (corresponding to 26 mg/dL) as increased, and 
over 2500 µmol/L as pathological.
Elliott et al (69) measured beta-hydroxybutyrate concen-
trations in blood, urine, and the vitreous in a large series of 
fatalities including diabetics, alcoholics, and diabetic alco-
holics. In most cases, they observed comparable vitreous 
and blood beta-hydroxybutyrate values. Though urine be-
ta-hydroxybutyrate levels were not perfectly equivalent to 
blood levels, they proposed the same interpretative range 
for blood, vitreous, and urine beta-hydroxybutyrate val-
ues in order to diagnose ketoacidosis after death (normal 
<50 mg/L, corresponding to 480 µmol/L; increased 51-249 
mg/L, corresponding to 490-2390 µmol/L; pathologically 
significant: >250 mg/L, corresponding to 2400 µmol/L).
The findings of these studies were corroborated by our 
own investigations, which also confirmed that fatal DKA 
can be diagnosed using vitreous humor as an alternative 
to postmortem blood with a beta-hydroxybutyrate cut-off 
value of 2500 µmol/L. Besides the vitreous, our analyses 
indicated that pericardial fluid can also be reliably ana-
lyzed for beta-hydroxybutyrate determination should 
blood prove unavailable during autopsy (61).
The usefulness of vitreous beta-hydroxybutyrate determi-
nation for the postmortem diagnosis of diabetes mellitus 
has also been emphasized by Osuna et al (55) and Heni-
ger (70). The latter author proposed a series of consecutive 
vitreous beta-hydroxybutyrate levels varying from normal 
(<400 µmol/L, corresponding to approximately 40 mg/L) 
to significantly elevated (2000-6000 µmol/L, 200-625 
mg/L), and definitely indicating life-threatening conditions 
(>6000 µmol/L).
Biochemical investigations focusing on beta-hydroxybu-
tyrate concentrations in blood, vitreous, urine, and ce-
rebrospinal fluid in alcoholics and diabetics were carried 
out by Kadiš et al (71) and Felby et al (72). Kadiš et al (71) 
found that beta-hydroxybutyrate levels in cerebrospinal 
fluid were significantly lower than those in blood, vitreous, 
and urine. The authors postulated that such results were 
the consequence of low ketone body permeability in the 
blood-brain barrier and concluded that cerebrospinal flu-
id was not appropriate for postmortem beta-hydroxybu-
tyrate determination. They also proposed a cut-off value 
of 3000 µmol/L (approximately 300 mg/L) in blood, urine, 
and vitreous to diagnose ketoacidosis. Felby et al (72) in-
vestigated beta-hydroxybutyrate concentrations in blood, 
vitreous, spinal fluid, and urine in a series of medico-legal 
autopsy cases and observed that urine had the lowest cor-
relation with blood beta-hydroxybutyrate levels. Moreover, 
spinal fluid values were generally lower than blood and vit-
reous levels. Though analogous results had already been 
described by Kadiš et al (71), diverging conclusions were 
drawn by Felby et al (72) concerning the usefulness of spi-
nal fluid in diagnosing ketoacidosis. Indeed, since spinal 
fluid is renewed more rapidly than the vitreous, Felby et 
al (72) concluded that spinal fluid was more reliable than 
the vitreous in reflecting the actual biochemical situation 
at the time of death.
Similar results were obtained by our group when we com-
pared blood, vitreous, urine, and pericardial and cerebro-
spinal fluid beta-hydroxybutyrate levels in diabetics and 
alcoholics. Cerebrospinal fluid concentrations were mostly 
lower than blood levels, thereby indicating that cerebro-
spinal fluid beta-hydroxybutyrate levels over 2000 µmol/L 
(200 mg/L), possibly corresponding to 2500 µmol/L (260 
mg/L) in blood, might be used to diagnose ketoacidosis 
after death. Urine beta-hydroxybutyrate values were usu-
ally higher than blood levels and significantly higher than 
blood levels on occasion. We therefore recommend cau-
tiousness when interpreting increased beta-hydroxybu-
tyrate urine levels using postmortem blood cut-off values.
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Though less precise than beta-hydroxybutyrate in diag-
nosing ketoacidosis in the postmortem setting, acetone 
levels in diabetics and alcoholics have been investigated 
by some research teams in blood and alternative biologi-
cal fluids (23,73-75). Pounder et al (73) measured levels of 
total ketone bodies in postmortem samples including the 
vitreous, pericardial fluid, and blood from different sam-
pling sites. Vitreous ketone body levels showed good cor-
relation with blood and pericardial fluid levels. Increased 
ketone body levels over 10000 µmol/L in blood (and over 
5000 µmol/L in the vitreous) were indicative of severe ke-
toacidosis. Brinkmann et al (74) investigated blood ac-
etone levels in a series of forensic cases and proposed a 
blood acetone cut-off value of 9 mg/dL (corresponding to 
1.5 mmol/L) as indicative of fatal ketoacidosis.
Interesting results were obtained by Palmiere et al (76,77), 
who measured beta-hydroxybutyrate levels in liver homo-
genates and synovial fluid. Beta-hydroxybutyrate concen-
trations in liver homogenates correlated well with blood 
values in both diabetic and non-diabetic patients and were 
not influenced by time after death, thus allowing diabetic 
ketoacidosis to be diagnosed. Analogously, blood and syn-
ovial fluid beta-hydroxybutyrate concentrations were cor-
related with increased blood levels reflected in increased 
synovial fluid concentrations (76,77).
As far as the influence that postmortem interval may have 
on postmortem beta-hydroxybutyrate levels, Iten and 
Meier (68) analyzed the relationship between blood beta-
hydroxybutyrate concentrations and time after death. No 
statistical increases in postmortem blood beta-hydroxybu-
tyrate levels were observed. These findings led to the con-
clusion that decompositional changes were not associated 
with beta-hydroxybutyrate production and that blood be-
ta-hydroxybutyrate levels in decomposed bodies could be 
considered an appropriate biochemical parameter in the 
estimation of beta-hydroxybutyrate concentrations at the 
time of death. Similar results were obtained in two studies, 
where we investigated blood beta-hydroxybutyrate levels 
in a series of medico-legal autopsies that included bodies 
with decompositional changes (15,78). Indeed, Kadiš et 
al (71) had already postulated that beta-hydroxybutyrate 
did not increase after death but, at most, decreased due to 
spontaneous molecule degradation.
isoProPYl AlCoHol
The concomitant presence of acetone and isopropyl al-
cohol in biological samples from living and deceased 
people was commonly accepted as the result of direct 
exposure to isopropyl alcohol. However, Robertson et al 
(79) observed isopropyl alcohol in the blood, milk, and 
rumen contents of cows suffering from acetonemia and 
speculated that acetone could be converted to isopropyl 
alcohol.
Lewis et al (80) subsequently postulated that alcohol de-
hydrogenase could reduce acetone to isopropyl alcohol in 
certain situations, including diabetes mellitus. They stud-
ied normal and diabetic rats and concluded that isopro-
pyl alcohol was a metabolic product of acetone, thereby 
providing an alternative explanation to direct isopropyl al-
cohol exposure for the increased isopropyl alcohol levels 
seen in humans.
Analogously, Davis et al (81) tested the hypothesis that in 
situations characterized by increased ketone body levels, 
the excessive amounts of acetone produced by the or-
ganism could enter a shunt mechanism resulting in its re-
duction to isopropyl alcohol. This might be especially true 
in the presence of an elevated NADH/NAD+ ratio, a bio-
chemical feature of ketotic states. The authors document-
ed the production of isopropyl alcohol from acetone in vit-
ro in the presence of the enzyme alcohol dehydrogenase 
and also reported increased acetone and isopropyl alcohol 
levels in the blood and tissues (liver, brain, and kidney) of 
8 individuals who had not been exposed to isopropyl al-
cohol. The highest isopropyl alcohol concentrations were 
noted in the liver, with isopropyl alcohol values exceeding 
those of acetone in that organ alone.
Buszewicz and Mądro (82) investigated the in vitro reduc-
tion of acetone to isopropyl alcohol in human homoge-
nates of the liver, brain, and lungs. They concluded that 
despite extremely significant individual differences, the ac-
etone-isopropyl alcohol conversion was a near-equimolar 
process, allowing the estimation of initial acetone concen-
trations via the summation of the molar concentrations of 
the two substances.
Isopropyl alcohol is currently considered a marker of ke-
toacidosis and a product of acetone metabolism in clinical 
conditions presenting increased ketone body levels. The 
compound can be detected in several situations of foren-
sic interest, beyond direct exposure to isopropyl alcohol 
itself, characterized by increased acetone levels and an el-
evated NADH/NAD+ ratio. These conditions include dia-
betic and alcoholic ketoacidosis as well as hypothermia 
fatalities and starvation (78).
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The results of isopropyl alcohol determination in cases of 
sudden death in diabetics have been reported among oth-
ers by Teresiński et al (75), with measured concentrations 
in femoral blood ranging from 1 to 15 µmol/L (0.06-0.90 
mg/L), and Palmiere et al (78), with measured concentra-
tions in femoral blood ranging from 330 to 1577 µmol/L 
(20-95 mg/L). In the latter study, isopropyl alcohol was also 
measured in urine and vitreous humor at concentrations 
ranging from 365 to 847 µmol/L (22-51 mg/L) and from 
282 to 813 µmol/L (17-49 mg/L), respectively.
Significantly higher blood and vitreous isopropyl alcohol 
concentrations in diabetics were found by Molina (83), 
with measured blood values ranging from 0 to 50 mg/
dL (median value 11.5 mg/dL) and vitreous values rang-
ing from 0 to 50 mg/dL (median value 8 mg/dL), and Pe-
tersen et al (84), who identified an average concentration 
of isopropyl alcohol of 15.1 ± 13.0 mg/dL in a series of 175 
DKA cases.
C-reACtiVe ProteiN
Besides the immediate biochemical derangements, such as 
the pathologically elevated glucose and ketone body levels 
that characterize the onset of DKA and are ultimately re-
sponsible for death, an increasing number of clinical stud-
ies have recently focused on biochemical markers that can 
identify or reveal the presence and progression of acute 
complications of DKA (essentially pulmonary and cerebral 
edema). These markers included C-reactive protein, high 
sensitivity C-reactive protein, interleukin 6, interleukin 10, 
interleukin 2, interleukin 4, interleukin 8, interleukin 1α, in-
terleukin 1β, and tumor necrosis factor alpha (TNF-α) (14).
In the realm of forensic pathology, C-reactive protein lev-
els in diabetic and alcoholic ketoacidosis have been inves-
tigated by Lindroos-Jokinen et al (85). These authors ob-
served that C-reactive protein levels could successfully 
be measured in postmortem material up to 18 days after 
death. Furthermore, they noted that ketoacidosis itself was 
associated with increased C-reactive protein levels without 
any other obvious, underlying causes. These might include 
infection or trauma, which typically lead to higher C-reac-
tive protein concentrations.
Analogously, Palmiere et al (14) observed increased C-re-
active protein, interleukin 6, and interleukin 10 levels in a 
series of fatal DKA cases, without any macroscopic or mi-
croscopic signs of bacterial infection. Moreover, in most 
of these cases, procalcitonin and lipopolysaccharide 
binding protein concentrations were at normal levels, thus 
corroborating the hypothesis of enhanced acute inflam-
matory responses in the course of DKA in the absence of 
obvious bacterial infection.
uriNe gluCose
At euglycemic blood glucose concentrations, glucose 
is freely filtered at the glomerulus and completely reab-
sorbed at the level of the proximal convoluted tubule. 
With rising blood glucose, the reabsorption of filtered glu-
cose in the proximal convoluted tubule increases until a 
maximum value is reached. Any further increase in blood 
glucose (and in the resultant glucose load presented to 
the proximal tubule) results in the excretion of glucose 
in urine. The appearance of glucose in urine is reflected 
in the concept of a renal threshold for glucose excretion. 
Theoretically, no glucose should be detectable in urine at 
sub-threshold blood glucose levels. Nevertheless, the ex-
cretion of glucose in urine in small amounts at euglycemic 
or sub-threshold blood glucose levels represents a phe-
nomenon described in the literature as basal glycosuria. 
Basal or physiological glycosuria is independent of blood 
glucose concentration, urinary flow rates, renal threshold 
for glucose, and maximal rate of tubular glucose absorp-
tion. These features suggest that physiological glycosuria 
does not reflect active transport system capacity in the 
proximal tubules, but may very well be the result of distal 
tubular leakage (86).
Although glucose is detectable in the urine of patients 
with increased blood glucose concentrations, its value in 
urine gives no information about blood glucose levels be-
low the renal threshold for glucose excretion, which vary 
considerably among individuals.
In the realm of forensic pathology, urine glucose in dia-
betics was studied by some research teams (6,17). Though 
high glucose values in urine were demonstrated only in 
cases of diabetic coma, glucose concentrations in urine 
were weakly correlated with glucose levels in vitreous and 
cerebrospinal fluid (6,17). These observations led to the 
conclusion that glucose value determination in urine is of 
low significance for the postmortem detection of diabetic 
coma. Increased urine glucose levels may be indicative of 
marked hyperglycemia. However, low urine glucose con-
centrations do not allow this hypothesis to be excluded. 
Hence, urinary glucose should be exclusively used to con-
firm consistent findings obtained from vitreous glucose 
and blood ketone body measurements (6,15,17).
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Mitchell et al (87) recently evaluated the usefulness of a 
rapid screening test in urine (urine “dipstick” testing using 
test strips) for the detection of increased glucose and ke-
tone body levels. They found that urinalysis (“dipstick” test-
ing) for glucose provided high specificity for high vitreous 
glucose levels, irrespective of the urinary result threshold. 
Conversely, urinalysis for ketone bodies provided either 
excellent sensitivity with low specificity or poor sensitiv-
ity with good specificity, depending on the urinary result 
threshold. According to the authors, these findings were 
likely due to the fact that test strips indicate levels of ac-
etoacetate, while the predominant ketone body of patho-
genic ketotic states is beta-hydroxybutyrate.
ureA NitrogeN, CreAtiNiNe, urAte, soDiuM, AND 
CHloriDe
Few fatal cases of hyperosmolar hyperlgycemic states 
(HHS) have been reported in the forensic literature. HHS 
is typically associated with type 2 diabetes and is charac-
terized by hyperglycemia, absent or small ketonuria, low 
ketonemia, hyperosmolarity, and profound dehydration. 
Both DKA and HHS result from a reduction in the amount 
or effective action of circulating serum insulin, producing 
intracellular starvation. The responding counterregulato-
ry mechanisms result in a state of hyperglycemia and li-
polysis, with subsequent hepatic fatty acid oxidation pro-
ducing ketone bodies. In HHS, however, plasma insulin 
concentrations may still be adequate to prevent lipolysis 
and subsequent ketogenesis, resulting in marked hyper-
glycemia, osmotic diuresis, and dehydration. The patient 
may experience profound water and electrolyte loss be-
fore presentation. If not managed properly, the risks in this 
compromised hemodynamic state include severe electro-
lyte disturbance, arrhythmia, rhabdomyolysis, renal fail-
ure, cardiovascular collapse, cerebral edema, and death 
(46,62,88,89). According to Hockenhull et al (62), death as a 
result of HHS is characterized by high glucose concentra-
tions, indicating hyperglycemia at the time of death, with 
no significant amount of ketone bodies detected.
Among the various biochemical markers investigated in 
the realm of forensic pathology, the results of numerous 
studies have demonstrated that urea nitrogen, creatinine, 
and uric acid are relatively stable in postmortem serum 
collected during autopsy. These may therefore be used 
for diagnostic purposes when dehydration and impaired 
renal function are investigated. Pericardial fluid urea nitro-
gen, creatinine, and urate have been demonstrated as rela-
tively stable within 48 hours postmortem, with levels un-
related to postmortem intervals. Moreover, urea nitrogen, 
creatinine, and urate concentrations in pericardial fluid are 
independent of sampled volume amounts, indicating no 
significant interference of postmortem water redistribu-
tion. Based on the results of these studies, it was postulat-
ed that pericardial fluid urea nitrogen, creatinine, and urate 
may be regarded as suitable biochemical markers for the 
pathophysiological investigation of situations in which de-
hydration and impaired renal function might be involved 
and postmortem serum unavailable (90-93).
Vitreous sodium levels have been determined to be rela-
tively stable during the early postmortem period and simi-
lar to levels found in the serum of living subjects. Accord-
ing to the literature, abnormalities in antemortem serum 
sodium concentrations are reflected in postmortem vitre-
ous values (16). Like sodium, vitreous chloride concentra-
tions show minimal falls in values during the early post-
mortem period and abnormalities in antemortem serum 
chloride are reflected in postmortem vitreous values (19).
CoNClusioNs
The identification of acute complications of diabetes mel-
litus as causes of death may be extremely challenging in 
forensic pathology routine due to the absence of specif-
ic signs at autopsy and histology. It has been repeatedly 
emphasized that biochemical analyses, especially vitre-
ous glucose determination, should systematically com-
plement postmortem investigations in all unexplained 
deaths. What has been shown in recent years is that bio-
chemical analyses can be performed after death even in 
corpses with advanced decompositional changes, using 
alternative specimens. Results obtained from these analy-
ses can still provide useful data for determining the cause 
of death.
Another point that deserves to be highlighted is that, apart 
from cases of fatal DKA in individuals with previously undi-
agnosed diabetes mellitus, numerous situations of foren-
sic interest may concern unintentional mismanagement of 
medical treatment (either insulin or hypoglycemic agents) 
in diabetics due to impaired judgment and/or uncon-
sciousness caused by concomitant drug (either recreation-
al or therapeutic) intoxication or potentially incapacitating 
diseases. This means that postmortem biochemical inves-
tigations should be systematically performed in both di-
agnosed and undiagnosed individuals in order to iden-
tify fatal complications of diabetes mellitus not only in 
all unexplained deaths with negative autopsy and 
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toxicology, but even when autopsy and toxicology results 
seem to provide apparently decisive findings.
To conclude, diabetes mellitus is expected to become one 
of the most serious health problems in the world in the 
near future. Clinical pathologists, forensic pathologists, and 
forensic toxicologists must be aware of the diagnostic po-
tential and limits of the available analyses and techniques. 
Determination of vitreous (or cerebrospinal fluid) glucose, 
blood (or alternative specimen) beta-hydroxybutyrate, and 
blood glycated hemoglobin are the standard analyses that 
any forensic laboratory should be able to carry out in order 
to detect potentially fatal disorders in glucose metabolism. 
Indeed, these analyses may allow DKA and HHS to be easily 
identified in both diagnosed and undiagnosed diabetics 
and a conclusive cause of death to be established in situa-
tions that would have otherwise remained unexplained.
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